Synthego Mops up US$110 mn to Democratize Gene Editing Technologies
CEO of Synthego Paul Dabrowski feels that genetically engineered cells made from genetic technologies could prove to be expensive for end users. To taRead More…
Latest News & Industry Insights
CEO of Synthego Paul Dabrowski feels that genetically engineered cells made from genetic technologies could prove to be expensive for end users. To taRead More…